Table 1 Demographics
From: Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
EAN/EADC | AAN^ | |
|---|---|---|
Age (mean (SD))* | 50.0 (8.7) | 54 (8.6) |
Gender, n female/total (%) | 26/84 (31%) | 21% |
Medical specialty, n (%) | ||
- Neurology | 74 (73%) | 94.4% |
- Geriatrics | 9 (8.8%) | 3.1% |
- Psychiatry | 9 (8.8%) | 3.4% |
- Neuropsychology | 2 (1.9%) | 4.4% |
- Combination of the above | 7 (6.9%) | NA |
Subspecialty training, n yes (%) | 65 (63.7%) | 59.6% |
Years of experience, n (%) | NA | |
- < 5 years | 7 (6.9%) | |
- 5–10 years | 15 (14.7%) | |
- 10–15 years | 20 (19.6%) | |
- 15–20 years | 20 (19.6%) | |
- > 20 years | 40 (39.2%) | |
Organization, n (%) | ||
- Solo practice | 5 (4.9%) | 30% |
- Group practice | 57 (59.9%) | 48.4% |
Single specialty group | 1 (1.0%) | |
Multispecialty group | 6 (5.9%) | |
University-based group | 50 (49%) | |
- Hospital or clinic | 38 (37.3%) | 17.9% |
Health care center | 2 (2.0%) | |
Government hospital or clinic | 28 (27.5%) | |
Other public or private hospital or clinical setting | 8 (7.8%) | |
- Other | 2 (2.0%) | 3.6% |
Number of respondents within a country, n | NA | |
- Turkey, Denmark, Finland, Georgia, Ireland, Israel, Luxembourg, Poland | 1 | |
- Austria, Belgium, Bulgaria, Norway, Slovenia, Portugal | 2 | |
- Sweden, Greece, Romania, Netherlands, France, Italy, UK | 3–6 | |
- Czech Republic, Germany | 7–9 | |
- Spain | 33 | |